These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 37195402)

  • 1. Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies.
    Toigo L; Dos Santos Teodoro EI; Guidi AC; Gancedo NC; Petruco MV; Melo EB; Tonin FS; Fernandez-Llimos F; Chierrito D; de Mello JCP; de Medeiros Araújo DC; Sanches ACC
    Daru; 2023 Jun; 31(1):51-68. PubMed ID: 37195402
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiviral Activity of Cinchona officinalis, a Homeopathic Medicine, against COVID-19.
    Arumugam S; Vadivel K; Dhaked DK; Prasanna VS; Yellurkar ML; Das P; Manoharan R; Thomas AJ; Singh L; Singh S; Velayutham R
    Homeopathy; 2024 Feb; 113(1):16-24. PubMed ID: 37673083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Black tea bioactives as inhibitors of multiple targets of SARS-CoV-2 (3CLpro, PLpro and RdRp): a virtual screening and molecular dynamic simulation study.
    Gogoi M; Borkotoky M; Borchetia S; Chowdhury P; Mahanta S; Barooah AK
    J Biomol Struct Dyn; 2022 Sep; 40(15):7143-7166. PubMed ID: 33715595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multi-targeted approach to identify potential flavonoids against three targets in the SARS-CoV-2 life cycle.
    Kumar S; Paul P; Yadav P; Kaul R; Maitra SS; Jha SK; Chaari A
    Comput Biol Med; 2022 Mar; 142():105231. PubMed ID: 35032740
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising Antiviral Activities of Natural Flavonoids against SARS-CoV-2 Targets: Systematic Review.
    Kaul R; Paul P; Kumar S; Büsselberg D; Dwivedi VD; Chaari A
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead Finding from Selected Flavonoids with Antiviral (SARS-CoV-2) Potentials Against COVID-19: An In-silico Evaluation.
    Gorla US; Rao K; Kulandaivelu US; Alavala RR; Panda SP
    Comb Chem High Throughput Screen; 2021; 24(6):879-890. PubMed ID: 32819226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of Dihydrobenzofuro[3,2-b]chromenes as Potential 3CLpro Inhibitors of SARS-CoV-2: A Molecular Docking and Molecular Dynamics Study.
    Gorai S; Junghare V; Kundu K; Gharui S; Kumar M; Patro BS; Nayak SK; Hazra S; Mula S
    ChemMedChem; 2022 Apr; 17(8):e202100782. PubMed ID: 35112482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic analyses to identify key structural features of antiviral/antimalarial compounds for their binding interactions with 3CLpro, PLpro and RdRp of SARS-CoV-2:
    Dhote AM; Patil VR; Lokwani DK; Amnerkar ND; Ugale VG; Charbe NB; Bhongade BA; Khadse SC
    J Biomol Struct Dyn; 2022; 40(22):11914-11931. PubMed ID: 34431452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic Aspects of Medicinal Plants and Secondary Metabolites against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Malekmohammad K; Rafieian-Kopaei M
    Curr Pharm Des; 2021; 27(38):3996-4007. PubMed ID: 34225607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Rudrapal M; Issahaku AR; Agoni C; Bendale AR; Nagar A; Soliman MES; Lokwani D
    J Biomol Struct Dyn; 2022; 40(20):10437-10453. PubMed ID: 34182889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of FDA approved drugs against SARS-CoV-2 RNA dependent RNA polymerase (RdRp) and 3-chymotrypsin-like protease (3CLpro), drug repurposing approach.
    Molavi Z; Razi S; Mirmotalebisohi SA; Adibi A; Sameni M; Karami F; Niazi V; Niknam Z; Aliashrafi M; Taheri M; Ghafouri-Fard S; Jeibouei S; Mahdian S; Zali H; Ranjbar MM; Yazdani M
    Biomed Pharmacother; 2021 Jun; 138():111544. PubMed ID: 34311539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effective inhibition of coronavirus replication by
    Xu H; Li J; Song S; Xiao Z; Chen X; Huang B; Sun M; Su G; Zhou D; Wang G; Hao R; Wang N
    Front Biosci (Landmark Ed); 2021 Oct; 26(10):789-798. PubMed ID: 34719206
    [No Abstract]   [Full Text] [Related]  

  • 14. Evaluation of the effects of chlorhexidine and several flavonoids as antiviral purposes on SARS-CoV-2 main protease: molecular docking, molecular dynamics simulation studies.
    Tatar G; Salmanli M; Dogru Y; Tuzuner T
    J Biomol Struct Dyn; 2022 Oct; 40(17):7656-7665. PubMed ID: 33749547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of 24-Propylcholestrol as Immunity Inducer against Infection of COVID-19 Virus:
    Kurnia D; Wiani I; Zainuddin A; Windaryanti D; Sondang Gabriel C
    Comb Chem High Throughput Screen; 2023; 26(2):383-391. PubMed ID: 35538835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of apigenin-based biflavonoid derivatives as potential therapeutic agents against viral protease (3CLpro) of SARS-CoV-2 via molecular docking, molecular dynamics and quantum mechanics studies.
    Abdizadeh R; Hadizadeh F; Abdizadeh T
    J Biomol Struct Dyn; 2023; 41(13):5915-5945. PubMed ID: 35848354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative evaluation of flavonoids reveals the superiority and promising inhibition activity of silibinin against SARS-CoV-2.
    Hamdy R; Mostafa A; Abo Shama NM; Soliman SSM; Fayed B
    Phytother Res; 2022 Jul; 36(7):2921-2939. PubMed ID: 35596627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-Targeted Molecular Docking and Drug-Likeness Evaluation of some Nitrogen Heterocyclic Compounds Targeting Proteins Involved in the Development of COVID-19.
    Hui LY; Mun CS; Sing LC; Rajak H; Karunakaran R; Ravichandran V
    Med Chem; 2023; 19(3):297-309. PubMed ID: 35713125
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study.
    Mishra GP; Bhadane RN; Panigrahi D; Amawi HA; Asbhy CR; Tiwari AK
    Comput Biol Med; 2021 Jul; 134():104464. PubMed ID: 34020130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenylbenzopyrone of Flavonoids as a Potential Scaffold to Prevent SARSCoV-2 Replication by Inhibiting its M
    Potshangbam AM; Nongdam P; Kumar AK; Rathore RS
    Curr Pharm Biotechnol; 2021; 22(15):2054-2070. PubMed ID: 33504301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.